The University of Chicago Header Logo

Connection

Richard A. Larson to Farnesyltranstransferase

This is a "connection" page, showing publications Richard A. Larson has written about Farnesyltranstransferase.
Connection Strength

0.116
  1. Four different regimens of farnesyltransferase inhibitor tipifarnib in older, untreated acute myeloid leukemia patients: North American Intergroup Phase II study SWOG S0432. Leuk Res. 2014 Mar; 38(3):329-33.
    View in: PubMed
    Score: 0.116
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.